Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis.
Coughlin CM, Salhany KE, Gee MS, LaTemple DC, Kotenko S, Ma X, Gri G, Wysocka M, Kim JE, Liu L, Liao F, Farber JM, Pestka S, Trinchieri G, Lee WM.
Coughlin CM, et al. Among authors: lee wm.
Immunity. 1998 Jul;9(1):25-34. doi: 10.1016/s1074-7613(00)80585-3.
Immunity. 1998.
PMID: 9697833
Free article.